Entos is a series b startup based in United States. 1 investor tracked.
Based in the United States, Entos is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Entos is a biotechnology company developing new therapeutics using its OrbNet platform, a structure-based drug design platform powered by machine learning. The company focuses on small molecule drug discovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.